• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adv Sci (Weinh) . Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago

tetano

Editor, Senior Moderator
Adv Sci (Weinh)


. 2021 Oct 29;e2102181.
doi: 10.1002/advs.202102181. Online ahead of print.
Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago


Min Qiang[SUP] 1 [/SUP], Peixiang Ma[SUP] 1 [/SUP], Yu Li[SUP] 1 2 3 4 [/SUP], Hejun Liu[SUP] 5 [/SUP], Adam Harding[SUP] 6 [/SUP], Chenyu Min[SUP] 7 [/SUP], Fulian Wang[SUP] 1 2 3 4 [/SUP], Lili Liu[SUP] 1 [/SUP], Meng Yuan[SUP] 5 [/SUP], Qun Ji[SUP] 1 [/SUP], Pingdong Tao[SUP] 1 2 3 4 [/SUP], Xiaojie Shi[SUP] 1 [/SUP], Zhean Li[SUP] 1 [/SUP], Teng Li[SUP] 1 2 3 4 [/SUP], Xian Wang[SUP] 1 2 3 4 [/SUP], Yu Zhang[SUP] 2 [/SUP], Nicholas C Wu[SUP] 5 [/SUP], Chang-Chun D Lee[SUP] 5 [/SUP], Xueyong Zhu[SUP] 5 [/SUP], Javier Gilbert-Jaramillo[SUP] 6 [/SUP], Chuyue Zhang[SUP] 1 2 3 4 [/SUP], Abhishek Saxena[SUP] 1 [/SUP], Xingxu Huang[SUP] 2 [/SUP], Hou Wang[SUP] 8 [/SUP], William James[SUP] 6 [/SUP], Raymond A Dwek[SUP] 9 [/SUP], Ian A Wilson[SUP] 5 10 [/SUP], Guang Yang[SUP] 1 7 [/SUP], Richard A Lerner[SUP] 11 [/SUP]



Affiliations

Abstract

Combinatorial antibody libraries not only effectively reduce antibody discovery to a numbers game, but enable documentation of the history of antibody responses in an individual. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has prompted a wider application of this technology to meet the public health challenge of pandemic threats in the modern era. Herein, a combinatorial human antibody library constructed 20 years before the coronavirus disease 2019 (COVID-19) pandemic is used to discover three highly potent antibodies that selectively bind SARS-CoV-2 spike protein and neutralize authentic SARS-CoV-2 virus. Compared to neutralizing antibodies from COVID-19 patients with generally low somatic hypermutation (SHM), these three antibodies contain over 13-22 SHMs, many of which are involved in specific interactions in their crystal structures with SARS-CoV-2 spike receptor binding domain. The identification of these somatically mutated antibodies in a pre-pandemic library raises intriguing questions about the origin and evolution of these antibodies with respect to their reactivity with SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-2; antibody-antigen interaction; combinatorial antibody library; neutralizing antibody; somatic hypermutation; variants of concern.
 
Back
Top Bottom